{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:42:58Z","timestamp":1785357778623,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T00:00:00Z","timestamp":1577664000000},"content-version":"vor","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Key R&D Program of China","award":["2018YFC0910500"],"award-info":[{"award-number":["2018YFC0910500"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31728012"],"award-info":[{"award-number":["31728012"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["17DZ22512000"],"award-info":[{"award-number":["17DZ22512000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Lishui medical key disciplines","award":["2016zdxk06"],"award-info":[{"award-number":["2016zdxk06"]}]},{"name":"Zhejiang laboratory animal science and technology","award":["2016C37145"],"award-info":[{"award-number":["2016C37145"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Spinal muscular atrophy (SMA) is a rare neuromuscular disorder threating hundreds of thousands of lives worldwide. And the severity of SMA differs among different clinical types, which has been demonstrated to be modified by factors like <jats:italic>SMN2<\/jats:italic>, <jats:italic>SERF1<\/jats:italic>, <jats:italic>NAIP<\/jats:italic>, <jats:italic>GTF2H2<\/jats:italic> and <jats:italic>PLS3<\/jats:italic>. However, the severities of many SMA cases, especially the cases within a family, often failed to be explained by these modifiers. Therefore, other modifiers are still waiting to be explored.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>In this study, we presented a rare case of SMA discordant family with a mild SMA male patient and a severe SMA female patient. The two SMA cases fulfilled the diagnostic criteria defined by the International SMA Consortium. With whole exome sequencing, we confirmed the heterozygous deletion of exon7 at <jats:italic>SMN1<\/jats:italic> on the parents\u2019 genomes and the homozygous deletions on the two patients\u2019 genomes. The MLPA results confirmed the deletions and indicated that all the family members carry two copies of <jats:italic>SMN2<\/jats:italic>, <jats:italic>SERF1<\/jats:italic>, <jats:italic>NAIP<\/jats:italic> and <jats:italic>GTF2H2<\/jats:italic>. Further genomic analysis identified compound heterozygous mutations at <jats:italic>TLL2<\/jats:italic> on the male patient\u2019s genome, and compound heterozygous mutations at <jats:italic>VPS13A<\/jats:italic> and the de novo mutation at <jats:italic>AGAP5<\/jats:italic> on female patient\u2019s genome. <jats:italic>TLL2<\/jats:italic> is an activator of myostatin, which negatively regulates the growth of skeletal muscle tissue. Mutation in <jats:italic>TLL2<\/jats:italic> has been proved to increase muscular function in mice model. <jats:italic>VPS13A<\/jats:italic> encodes proteins that control the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. And <jats:italic>AGAP5<\/jats:italic> was reported to have GTPase activator activity.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We reported a case of SMA discordant family and identified mutations at <jats:italic>TLL2<\/jats:italic>, <jats:italic>VPS13A<\/jats:italic> and <jats:italic>AGAP5<\/jats:italic> on the patients\u2019 genomes. The mutations at <jats:italic>TLL2<\/jats:italic> were predicted to be pathogenic and are likely to alleviate the severity of the male SMA patient. Our finding broadens the spectrum of genetic modifiers of SMA and will contribute to accurate counseling of SMA affected patients and families.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12881-019-0935-3","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T20:02:17Z","timestamp":1577736137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Genomic analysis of a spinal muscular atrophy (SMA) discordant family identifies a novel mutation in TLL2, an activator of growth differentiation factor 8 (myostatin): a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Jianping","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8347-0830","authenticated-orcid":false,"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,30]]},"reference":[{"issue":"9630","key":"935_CR1","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/S0140-6736(08)60921-6","volume":"371","author":"MR Lunn","year":"2008","unstructured":"Lunn MR, Wang CH. Spinal muscular atrophy. Lancet. 2008;371(9630):2120\u201333.","journal-title":"Lancet"},{"issue":"Database issue","key":"935_CR2","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","volume":"43","author":"JS Amberger","year":"2015","unstructured":"Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. OMIM.org: online Mendelian inheritance in man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2015;43(Database issue):D789\u201398.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"935_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC, Cook SF, Lochmuller H. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet J Rare Dis. 2017;12(1):124.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"935_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70(2):358\u201368.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"935_CR5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00415-002-0811-4","volume":"249","author":"Y Harada","year":"2002","unstructured":"Harada Y, Sutomo R, Sadewa AH, Akutsu T, Takeshima Y, Wada H, Matsuo M, Nishio H. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: three SMN2 copies fail to rescue some patients from the disease severity. J Neurol. 2002;249(9):1211\u20139.","journal-title":"J Neurol"},{"issue":"1","key":"935_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/1753","volume":"20","author":"JM Scharf","year":"1998","unstructured":"Scharf JM, Endrizzi MG, Wetter A, Huang S, Thompson TG, Zerres K, Dietrich WF, Wirth B, Kunkel LM. Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Nat Genet. 1998;20(1):83\u20136.","journal-title":"Nat Genet"},{"issue":"1","key":"935_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0092-8674(95)90461-1","volume":"80","author":"N Roy","year":"1995","unstructured":"Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S, Besner-Johnston A, Lefebvre C, Kang X, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell. 1995;80(1):167\u201378.","journal-title":"Cell"},{"issue":"1","key":"935_CR8","first-page":"72","volume":"60","author":"L Burglen","year":"1997","unstructured":"Burglen L, Seroz T, Miniou P, Lefebvre S, Burlet P, Munnich A, Pequignot EV, Egly JM, Melki J. The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. Am J Hum Genet. 1997;60(1):72\u20139.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"935_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346.","journal-title":"Neurol Clin"},{"issue":"1","key":"935_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ped.13052","volume":"59","author":"IH Yener","year":"2017","unstructured":"Yener IH, Topaloglu H, Erdem-Ozdamar S, Dayangac-Erden D. Transcript levels of plastin 3 and neuritin 1 modifier genes in spinal muscular atrophy siblings. Pediatr Int. 2017;59(1):53\u20136.","journal-title":"Pediatr Int"},{"issue":"12","key":"935_CR11","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/hmg\/dds102","volume":"21","author":"S Ahmad","year":"2012","unstructured":"Ahmad S, Wang Y, Shaik GM, Burghes AH, Gangwani L. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Hum Mol Genet. 2012;21(12):2745\u201358.","journal-title":"Hum Mol Genet"},{"issue":"5875","key":"935_CR12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","volume":"320","author":"GE Oprea","year":"2008","unstructured":"Oprea GE, Krober S, McWhorter ML, Rossoll W, Muller S, Krawczak M, Bassell GJ, Beattie CE, Wirth B. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science. 2008;320(5875):524\u20137.","journal-title":"Science"},{"issue":"25","key":"935_CR13","doi-asserted-by":"publisher","first-page":"10337","DOI":"10.1073\/pnas.1104928108","volume":"108","author":"B Akten","year":"2011","unstructured":"Akten B, Kye MJ, le Hao T, Wertz MH, Singh S, Nie D, Huang J, Merianda TT, Twiss JL, Beattie CE, et al. Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc Natl Acad Sci U S A. 2011;108(25):10337\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"935_CR14","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"7","key":"935_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073\u201381.","journal-title":"Nat Protoc"},{"issue":"4","key":"935_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"D1","key":"935_CR17","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"935_CR18","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1038\/ng.3703","volume":"48","author":"KA Jagadeesh","year":"2016","unstructured":"Jagadeesh KA, Wenger AM, Berger MJ, Guturu H, Stenson PD, Cooper DN, Bernstein JA, Bejerano G. M-CAP eliminates a majority of variants of uncertain significance in clinical exomes at high sensitivity. Nat Genet. 2016;48(12):1581\u20136.","journal-title":"Nat Genet"},{"issue":"5","key":"935_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/bioinformatics\/btu703","volume":"31","author":"D Quang","year":"2015","unstructured":"Quang D, Chen Y, Xie X. DANN: a deep learning approach for annotating the pathogenicity of genetic variants. Bioinformatics. 2015;31(5):761\u20133.","journal-title":"Bioinformatics"},{"issue":"3","key":"935_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btx536","volume":"34","author":"MF Rogers","year":"2018","unstructured":"Rogers MF, Shihab HA, Mort M, Cooper DN, Gaunt TR, Campbell C. FATHMM-XF: accurate prediction of pathogenic point mutations via extended features. Bioinformatics. 2018;34(3):511\u20133.","journal-title":"Bioinformatics"},{"issue":"11","key":"935_CR21","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/gim.2016.13","volume":"18","author":"J Kleinberger","year":"2016","unstructured":"Kleinberger J, Maloney KA, Pollin TI, Jeng LJ. An openly available online tool for implementing the ACMG\/AMP standards and guidelines for the interpretation of sequence variants. Genet Med. 2016;18(11):1165.","journal-title":"Genet Med"},{"issue":"2","key":"935_CR22","doi-asserted-by":"publisher","first-page":"e1628","DOI":"10.1371\/journal.pone.0001628","volume":"3","author":"SJ Lee","year":"2008","unstructured":"Lee SJ. Genetic analysis of the role of proteolysis in the activation of latent myostatin. PLoS One. 2008;3(2):e1628.","journal-title":"PLoS One"},{"issue":"7","key":"935_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/hmg\/ddy382","volume":"28","author":"KK Long","year":"2019","unstructured":"Long KK, O'Shea KM, Khairallah RJ, Howell K, Paushkin S, Chen KS, Cote SM, Webster MT, Stains JP, Treece E, et al. Specific inhibition of myostatin activation is beneficial in mouse models of SMA therapy. Hum Mol Genet. 2019;28(7):1076\u201389.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"935_CR24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1086\/514876","volume":"61","author":"JP Rubio","year":"1997","unstructured":"Rubio JP, Danek A, Stone C, Chalmers R, Wood N, Verellen C, Ferrer X, Malandrini A, Fabrizi GM, Manfredi M, et al. Chorea-acanthocytosis: genetic linkage to chromosome 9q21. Am J Hum Genet. 1997;61(4):899\u2013908.","journal-title":"Am J Hum Genet"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-019-0935-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-019-0935-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:12:34Z","timestamp":1609200754000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-019-0935-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["935"],"URL":"https:\/\/doi.org\/10.1186\/s12881-019-0935-3","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"16 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from all participants or their parents (for minors), and the Ethics Committee of the Sixth Affiliated Hospital of Wenzhou Medical University approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants or their parents (for minors) included in this report for the use of clinical-related materials for scientific research and publications. These materials include medical information, genetic testing results and other related data used in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}